advanced medical device News
-
Mundomedis Acquires US Medical Device Manufacturer, TNMI
Mundomedis recently acquired 96% of the common shares of US-based medical device manufacturer, Tennessee Medical Innovations Inc. (TNMI). TNMI will serve as Mundomedis’ platform for further medical device investments and acquisitions which Mundomedis is currently evaluating. Besides the financial investment, TNMI will benefit from Mundomedis’ global sales & marketing ...
-
Mundomedis Portfolio Company Tennessee Medical Innovations INC, USA, Announces Acquisition of the Assets of Insightra Medical INC.
Mundomedis announced it has closed on the acquisition by its wholly-owned portfolio company, Tennessee Medical Innovations INC. (TNMI), of substantially all assets of Insightra Medical Inc., as a US-based medical device manufacturer. Insightra Medical was founded in 2001 and develops, manufactures and markets innovative medical devices for orthopedic, cardiovascular and hernia related medical ...
-
Oncomfort receives ISO 13485:2016 certification
ncomfort, the leader in Digital Sedation™, a digital therapy to relieve patient anxiety and pain, today announces that it has obtained the ISO 13485:2016 certification by certification company DARE!! Services. This certification confirms that Oncomfort manages the design, manufacturing and distribution of its Digital Sedation™ medical device and its Sedakit™, in its quality ...
By Oncomfort
-
NeoTherma Oncology Receives NCI Grant to Advance VectRx MRI Thermometry
NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the Company was recently awarded Small Business Innovation Research grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). This Phase I award provides resources to enable 'Quantifiable Thermal Therapy Using Magnetic ...
-
EMOSIS reinforces its Intellectual Property and scientific expertise
The French innovative Medical Device start-up Emosis, specializing in cytomolecular diagnostics of thrombosis and hemostasis disorders, is reinforcing its intellectual property on HIT Confirm®, Emosis first test kit which was recently launched in Europe (CE Mark). The company was granted a US patent “Platelet Analysis System” (US10, 012,658 B2), and the PCT of the patent ...
-
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand Pharmaceutical Group Limited, (Grand Pharma) for its proprietary Saturn device in Greater China. The transaction pulled in ...
-
Field Orthopaedics announced as Finalist in Lord Mayor’s Awards
Field Orthopaedics is proud to have been recognised as a finalist for the ‘HSBC Award for Excellence in International Business’ in the 2021 Lord Mayor’s Awards, an initiative of the Brisbane City Council where the FO headquarters are based. The awards attract thousands of entries each year, highlighting the calibre of Field Orthopaedics’ submission and the success of the ...
-
Two ministries support the domestic medical equipment and will establish incentive mechanism
Recently, the National Health Commission and the Ministry of Industry jointly held the conference to promote the development and application of domestic medical equipment, the domestic medical equipment upgrades once again become the focus. Miao Wei, Minister of Industry and Information, said that in order to promote the development of domestic medical equipment industry, will establish the ...
-
NeoTherma Oncology Raises $6 Million to Advance VectRx to Human Testing
NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the closing of a $6 million capital raise. The financing provides the resources to conduct human testing of NTO's VectRx™ thermal oncology treatment platform, designated by FDA as a 'Breakthrough Therapy' for Pancreatic Cancer, expediting patient access ...
-
Nuubo Receives US FDA 510 (k) Clearance for the Nuubo System
Spanish medical device innovator Nuubo (https://www.nuubo.com) today announced it has received United States Food and Drug Administration (FDA) 510 (k) clearance to market its Nuubo System, a disruptive wireless, textile-based ambulatory electrocardiogram (aECG) technology that enables mid and long-term monitoring for cardiac arrhythmia ...
By Nuubo
-
Winner at the 2020 Med-Tech Awards - Numedico
It is with pleasure that we can announce that Numedico Technologies has been nominated as a winner in the 2020 Global Med-Tech Awards. Announced this week, Global Health and Pharma Magazine published the results of the 3rd annual MedTech Awards. This year the GHP News Medtech Awards 2020, celebrated those who have demonstrated an ability to innovate in this industry. Shining in this dynamic ...
-
Showcase
Neurescue`s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...
By Neurescue
-
FDA Proposal Responds To President Obama Order
The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) published on January 19, 2011, a “plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.” See FDA News Release, “FDA to improve most common review path for medical devices” (Jan. 19, 2011), available ...
By Acta Group
-
FDA Proposal Responds to President Obama Order
The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) published on January 19, 2011, a “plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.” See FDA News Release, “FDA to improve most common review path for medical devices” (Jan. 19, 2011), available ...
-
Contraline CEO to Present at the 43rd American Society of Andrology Conference
April 22, 2018 – Charlottesville, Virginia – Kevin Eisenfrats, Co-Founder and CEO of Contraline, Inc., will be sharing the history, current-state-of-the-art, and innovation in vas-occlusive medical devices in a featured talk at the American Society of Andrology 43rd Annual Conference in Portland, Oregon. His talk, titled “The Past, Present, and Future of Vas-Occlusive Medical ...
-
Andrew Cleeland joins atHeart Medical’s Board
atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the appointment of Andrew Cleeland to the company’s Board of Directors. With over thirty years of experience, including specific expertise bringing game-changing technologies to market, Mr. ...
-
The Centers for Medicare and Medicaid (CMS) announced the MCIT pathway to provide national Medicare coverage for FDA Breakthrough Devices and Diagnostic
The Centers for Medicaid and Medicare (CMS) announced the establishment of the MCIT (Medicare Coverage of Innovative Technology) pathway, which is designed to provide coverage and access to new, innovative medical devices and diagnostics which have received FDA Breakthrough Device Designation to Medicare beneficiaries nationwide. Through this pathway, Breakthrough devices will automatically be ...
-
US. Sen. Tammy Baldwin visits Attwill Medical Solutions
Attwill Medical Solutions was proud to host U.S. Senator Tammy Baldwin (D-WI) today for a. roundtable discussion regarding the company, as well as a comprehensive factory tour. Attwill Medical. Solutions is one of the largest manufacturers of reagents for COVID-19 and other PCR testing kits, and. has unique freeze-drying technology, which may be utilized for the development of vaccines in a pill. ...
-
Proa Medical, Inc. Receives China and Russia Patent Grants for its First Device for Women’s Health
Proa Medical, Inc., developer of innovative and practical medical devices for women’s health, today announced that it has been granted patents in China and Russia covering the company’s first product, the Brella Vaginal Retractor. (Proa Medical was granted a United States patent covering the Brella Vaginal Retractor from the United States Patent and Trademark Office on June 9, 2015.) ...
-
Proa Medical Receives Positive Reception for Brella Vaginal Retractor at Mexican Congress of Gynecology and Obstetrics
Proa® Medical, Inc., developer of innovative and practical medical devices for women’s health, today announced that the company received significant positive feedback for its FDA-cleared Brella® Vaginal Retractor at the recent 64° Congreso Mexicano de Ginecología y Obstetricia, the largest U.S. congress for women’s health, held in Mexico City. The Brella® ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you